Austin Bond
About Austin Bond
Austin Bond is an Associate Computational Biologist II at the Broad Institute of MIT and Harvard, where he focuses on drug discovery against infectious pathogens. He has a background in computational biology and has held various roles in research and data analysis since 2017.
Work at Broad Institute
Austin Bond currently serves as an Associate Computational Biologist II at the Broad Institute of MIT and Harvard, a position he has held since 2024. Prior to this role, he worked as an Associate Computational Biologist I from 2022 to 2024 and as a Research Associate II from 2021 to 2022. In these roles, he focuses on drug discovery against infectious pathogens, including Mycobacterium tuberculosis, Pseudomonas aeruginosa, and Mycobacterium abscessus. He leads automation tasks utilizing Agilent Bravo and BenchCel systems within the Microbial Genetics Group/Hung Lab and is responsible for high-throughput Illumina-based library construction for multistrain screenings.
Education and Expertise
Austin Bond earned a Bachelor of Science degree in Computational and Systems Biology and Molecular, Cell, and Developmental Biology from UCLA, where he studied from 2016 to 2020. His educational background provides a strong foundation for his current work in computational biology and drug discovery. He has developed expertise in antibiotic resistance research and computational tasks related to drug discovery, which he applies in his current role at the Broad Institute.
Background
Austin Bond has a diverse professional background that includes various roles prior to his current position at the Broad Institute. He worked as a Junior Data Delivery Analyst at RK in 2018 and served as a Community Service Officer at the UCLA Police Department in 2017. Additionally, he gained research experience as an Undergraduate Research Assistant with the UCLA Depression Grand Challenge from 2018 to 2020. His early work experience includes roles in animal care and customer service, showcasing a range of skills.
Achievements in Drug Discovery
In his current role at the Broad Institute, Austin Bond contributes to significant advancements in drug discovery against infectious pathogens. He leads automation tasks and is responsible for high-throughput library construction for multistrain screenings, which involves strain-specific DNA barcode counts. His work supports ongoing research efforts aimed at combating antibiotic resistance and improving treatment options for infectious diseases.